Literature DB >> 1649701

Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.

A B Lassar1, R L Davis, W E Wright, T Kadesch, C Murre, A Voronova, D Baltimore, H Weintraub.   

Abstract

In this report we provide four lines of evidence indicating that E12/E47-like proteins interact in vivo with the myogenic HLH proteins MyoD and myogenin. First, cotransfection of MyoD and E47 in COS cells indicates that these factors synergistically enhance transcription of a reporter gene containing an oligomerized MyoD-binding site. Second, mobility-shift assays of muscle cell nuclear extracts, "double shifted" with specific antisera, have identified complexes binding to the MEF1 site that contain either MyoD or myogenin in association with E12/E47-like proteins. Third, association with E47 alters the phosphorylation state of MyoD. Fourth, C3H10T1/2 cells expressing antisense E2A transcripts contain low levels of E2A gene products and display less terminal muscle differentiation when infected with retroviral MyoD or when challenged to differentiate with 5-azacytidine treatment. In addition we demonstrate that MyoD, in conjunction with E12/E47-like proteins, is functioning as a regulatory nodal point for activation of several other downstream muscle regulators.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649701     DOI: 10.1016/0092-8674(91)90620-e

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  270 in total

1.  Establishment of distinct MyoD, E2A, and twist DNA binding specificities by different basic region-DNA conformations.

Authors:  T Kophengnavong; J E Michnowicz; T K Blackwell
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.

Authors:  T H Christensen; L Kedes
Journal:  Gene Expr       Date:  1999

3.  cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.

Authors:  M Kitzmann; M Vandromme; V Schaeffer; G Carnac; J C Labbé; N Lamb; A Fernandez
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

4.  Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4.

Authors:  J M Zhang; Q Wei; X Zhao; B M Paterson
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

5.  Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis.

Authors:  J G Toma; H El-Bizri; F Barnabe-Heider; R Aloyz; F D Miller
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

6.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

7.  Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.

Authors:  A Polesskaya; I Naguibneva; A Duquet; E Bengal; P Robin; A Harel-Bellan
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase.

Authors:  Alison M O'Mahony; Donal A Walsh
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

9.  Regulation of E-box DNA binding during in vivo and in vitro activation of rat and human hepatic stellate cells.

Authors:  K J Vincent; E Jones; M J Arthur; D E Smart; J Trim; M C Wright; D A Mann
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

Review 10.  A genetic investigation of E2A function in lymphocyte development.

Authors:  J Hanrahan; L Pan; S Greenbaum; C Bradney; M Hjelmeland; M Dai; Y Zhuang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.